rs113994208
Variant summary
Our verdict is Pathogenic. Variant got 14 ACMG points: 14P and 0B. PM2PP3_StrongPP5_Very_Strong
The NM_004937.3(CTNS):c.613G>A(p.Asp205Asn) variant causes a missense change involving the alteration of a conserved nucleotide. The variant allele was found at a frequency of 0.0000112 in 1,613,244 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a pathogenic outcome for this variant. Variant has been reported in ClinVar as Pathogenic (★★).
Frequency
Consequence
NM_004937.3 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Pathogenic. Variant got 14 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | Exon rank | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
CTNS | NM_004937.3 | c.613G>A | p.Asp205Asn | missense_variant | Exon 9 of 12 | ENST00000046640.9 | NP_004928.2 |
Ensembl
Frequencies
GnomAD3 genomes AF: 0.0000132 AC: 2AN: 151774Hom.: 0 Cov.: 29
GnomAD3 exomes AF: 0.00000796 AC: 2AN: 251332Hom.: 0 AF XY: 0.00 AC XY: 0AN XY: 135902
GnomAD4 exome AF: 0.0000109 AC: 16AN: 1461470Hom.: 0 Cov.: 33 AF XY: 0.0000110 AC XY: 8AN XY: 727042
GnomAD4 genome AF: 0.0000132 AC: 2AN: 151774Hom.: 0 Cov.: 29 AF XY: 0.0000135 AC XY: 1AN XY: 74084
ClinVar
Submissions by phenotype
Cystinosis Pathogenic:2
Variant summary: The CTNS c.613G>A (p.Asp205Asn) variant causes a missense change involving the alteration of a conserved nucleotide. 4/5 in silico tools predict a damaging outcome for this variant. Multiple studies confirmed that this variant is abolishing cysteine transport (Kalatzis_HMG_2004, Ruivo_PNAS_2011). The variant of interest has not been found in a large, broad control population, ExAC in 120966 control chromosomes and was found in gnomAD in 2/246212 at a frequency of 0.000008123 which does not exceed the estimated maximal expected allele frequency of a pathogenic CTNS variant (0.0025). This variant was reported in multiple patients with cystinosis, including 2 compound heterozigotes with CTNS p.S298N and 57 kb deletion, respectively and in one homozygote with osteogenesis imperfecta (Shotelersuk_AJHG_1998, Kalatzis_HMG_2004). In addition, one reputable database classified this variant as pathogenic. Taken together, this variant is classified as pathogenic. -
- -
Nephropathic cystinosis Pathogenic:1Other:1
- -
- -
not provided Pathogenic:1
Published functional studies demonstrate a damaging effect: abolished cystine transport (Kalatzis et al., 2004); Not observed at significant frequency in large population cohorts (gnomAD); This variant is associated with the following publications: (PMID: 35571017, 28186126, 15128704, 34237326, Ghazi2017[casereport], 35513889, 20301574, 28793998, 30949462, 36113465, 28983406, 22528245, 9792862) -
Juvenile nephropathic cystinosis;C0950123:Inborn genetic diseases;C2931013:Ocular cystinosis Pathogenic:1
This sequence change replaces aspartic acid, which is acidic and polar, with asparagine, which is neutral and polar, at codon 205 of the CTNS protein (p.Asp205Asn). This variant is present in population databases (rs113994208, gnomAD 0.003%). This missense change has been observed in individual(s) with cystinosis (PMID: 9792862, 22528245, 28983406). ClinVar contains an entry for this variant (Variation ID: 21440). Advanced modeling of protein sequence and biophysical properties (such as structural, functional, and spatial information, amino acid conservation, physicochemical variation, residue mobility, and thermodynamic stability) performed at Invitae indicates that this missense variant is expected to disrupt CTNS protein function with a positive predictive value of 80%. Experimental studies have shown that this missense change affects CTNS function (PMID: 15128704, 22232659). For these reasons, this variant has been classified as Pathogenic. -
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at